Why is Morepen Labs. falling/rising?

As of 05-Sep, Morepen Laboratories Ltd is experiencing a decline in its stock price, currently at 49.31, reflecting a decrease of 0.27 or 0.54%. The stock has underperformed its sector by 0.47% today and has been on a downward trend for the last two days, with a total decline of 1.54%. Over the past week, the stock has shown a positive return of 5.66%, but it has significantly underperformed over the longer term, with a 12.82% decline over the past month and a staggering 47.25% drop over the past year. The company has reported negative results in the last two quarters, with a notable fall in net sales and profits, which has contributed to its poor performance. Despite having a low debt-to-equity ratio and an attractive valuation compared to peers, the overall sentiment remains negative due to the company's declining sales and lack of domestic mutual fund investment. In the broader market context, while the Sensex has remained flat over the past month, Morepen Laboratories Ltd's performance has been considerably worse, highlighting its struggles relative to the benchmark. The stock's recent performance, particularly its consecutive falls and negative quarterly results, indicates a lack of investor confidence, which is further compounded by the fact that domestic mutual funds hold no stake in the company. This lack of institutional support may signal discomfort with the company's current valuation and business prospects, contributing to the stock's downward trajectory.